Federated Hermes Inc. Has $65.91 Million Position in Maximus, Inc. (NYSE:MMS)

Federated Hermes Inc. lifted its position in Maximus, Inc. (NYSE:MMS - Free Report) by 74.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 882,953 shares of the health services provider's stock after acquiring an additional 377,705 shares during the quarter. Federated Hermes Inc. owned 1.55% of Maximus worth $65,912,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. UMB Bank n.a. boosted its holdings in Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after purchasing an additional 158 shares during the period. Eastern Bank acquired a new position in shares of Maximus in the 4th quarter valued at about $29,000. V Square Quantitative Management LLC boosted its holdings in shares of Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after buying an additional 180 shares during the period. R Squared Ltd bought a new stake in shares of Maximus during the 4th quarter valued at about $54,000. Finally, IFP Advisors Inc lifted its holdings in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after acquiring an additional 302 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Maximus Stock Performance

Maximus stock traded up $0.94 during mid-day trading on Friday, hitting $68.41. 527,898 shares of the company's stock traded hands, compared to its average volume of 548,296. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.97. The firm has a 50 day moving average price of $67.90 and a 200 day moving average price of $76.15. The company has a market cap of $3.87 billion, a PE ratio of 14.71 and a beta of 0.68.

Remove Ads

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, equities analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.75%. Maximus's dividend payout ratio is presently 25.81%.

Analysts Set New Price Targets

Several research firms have recently commented on MMS. StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd.

Insider Buying and Selling

In related news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares of the company's stock, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.